JP2017524743A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524743A5 JP2017524743A5 JP2017528767A JP2017528767A JP2017524743A5 JP 2017524743 A5 JP2017524743 A5 JP 2017524743A5 JP 2017528767 A JP2017528767 A JP 2017528767A JP 2017528767 A JP2017528767 A JP 2017528767A JP 2017524743 A5 JP2017524743 A5 JP 2017524743A5
- Authority
- JP
- Japan
- Prior art keywords
- bioactive agent
- composition
- matrix
- composition according
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462037492P | 2014-08-14 | 2014-08-14 | |
| US62/037,492 | 2014-08-14 | ||
| PCT/US2015/045402 WO2016025911A1 (en) | 2014-08-14 | 2015-08-14 | Compositions for stabilizing and delivering proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017524743A JP2017524743A (ja) | 2017-08-31 |
| JP2017524743A5 true JP2017524743A5 (enExample) | 2018-09-27 |
| JP6910949B2 JP6910949B2 (ja) | 2021-07-28 |
Family
ID=54011102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017528767A Active JP6910949B2 (ja) | 2014-08-14 | 2015-08-14 | タンパク質を安定化させ、送達するための組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10722468B2 (enExample) |
| EP (1) | EP3179985A1 (enExample) |
| JP (1) | JP6910949B2 (enExample) |
| AU (1) | AU2015301399B2 (enExample) |
| CA (1) | CA2957966C (enExample) |
| WO (1) | WO2016025911A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102218427B1 (ko) | 2017-09-20 | 2021-02-22 | 차의과학대학교 산학협력단 | 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제 |
| KR101883142B1 (ko) * | 2017-10-30 | 2018-07-30 | 아주대학교산학협력단 | Sdf1을 유효성분으로 포함하는 피부 색소 형성 조절용 조성물 또는 피부 미백용 조성물 |
| US20210031012A1 (en) | 2018-01-26 | 2021-02-04 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
| US20230041197A1 (en) | 2018-06-20 | 2023-02-09 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| EP3810268A1 (en) | 2018-06-20 | 2021-04-28 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor |
| WO2019246455A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| WO2019246317A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease or condition in a tissue originating from the endoderm |
| US12171764B2 (en) | 2018-06-20 | 2024-12-24 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor |
| WO2019246313A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a tnf inhibitor |
| WO2020028907A1 (en) | 2018-08-03 | 2020-02-06 | Brown University | Compositions and methods for improving the bioavailability of glp1 and analogues thereof |
| CA3115677A1 (en) | 2018-10-19 | 2020-04-23 | University Of Rochester | Immune modulators in combination with radiation treatment for advanced pancreatic cancer |
| MX2021009851A (es) | 2019-02-18 | 2021-09-10 | Lilly Co Eli | Formulacion de anticuerpos terapeuticos. |
| WO2021034727A1 (en) | 2019-08-16 | 2021-02-25 | Applied Molecular Transport Inc. | Compositions, formulations, and interleukin production and purification |
| EP4464339A1 (en) * | 2022-01-13 | 2024-11-20 | National Cancer Center | Biocompatible composition for labeling target lesion, and preparation method therefor |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB929406A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | A process for the production of encapsulated material |
| GB929401A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | Encapsulated emulsions and processes for their preparation |
| GB969808A (en) | 1962-06-08 | 1964-09-16 | Boots Pure Drug Co Ltd | Anthelmintic compositions and compounds |
| GB1413186A (en) | 1973-06-27 | 1975-11-12 | Toyo Jozo Kk | Process for encapsulation of medicaments |
| IT1148784B (it) | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
| US4794000A (en) | 1987-01-08 | 1988-12-27 | Synthetic Blood Corporation | Coacervate-based oral delivery system for medically useful compositions |
| US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| US5330768A (en) | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
| US6197346B1 (en) | 1992-04-24 | 2001-03-06 | Brown Universtiy Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
| US6235313B1 (en) | 1992-04-24 | 2001-05-22 | Brown University Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
| WO1995024929A2 (en) | 1994-03-15 | 1995-09-21 | Brown University Research Foundation | Polymeric gene delivery system |
| GB9506946D0 (en) | 1995-04-04 | 1995-05-24 | Univ Strathclyde | Microgels |
| US6143211A (en) | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
| US6025393A (en) * | 1995-09-25 | 2000-02-15 | Santen Pharmaceutical Co., Ltd. | Method for treatment of inflammatory intestinal diseases |
| US6423345B2 (en) * | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| JP4526708B2 (ja) * | 1998-09-01 | 2010-08-18 | メリオン リサーチ スリー リミテッド | 細胞を媒介した免疫応答を誘導する方法及びそのための非経口ワクチン製剤 |
| EP1246609B1 (en) | 2000-01-14 | 2010-03-31 | Brown University Research Foundation | Process for making micronized freeze-dried particles |
| US6998137B2 (en) * | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| US20020106406A1 (en) * | 2000-12-08 | 2002-08-08 | Mchugh Anthony J. | Crystallizable/non-crystallizable polymer composites |
| EP1492554B1 (en) * | 2001-06-21 | 2019-08-21 | Althea Technologies, Inc. | Spherical protein particles |
| CN1694689A (zh) * | 2002-09-30 | 2005-11-09 | 阿库斯菲尔公司 | 供吸入的缓释多孔微粒 |
| EP1631312B1 (en) * | 2003-04-23 | 2008-09-10 | Medarex, Inc. | Compositions and methods for the therapy of inflammatory bowel disease |
| WO2006002365A2 (en) * | 2004-06-24 | 2006-01-05 | Angiotech International Ag | Microparticles with high loadings of a bioactive agent |
| US20060228352A1 (en) | 2005-02-24 | 2006-10-12 | Schoenberger Stephen P | TRAIL and methods of modulating T cell activity and adaptive immune responses using TRAIL |
| EP2026771B1 (en) | 2006-01-23 | 2009-10-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Microspheres comprising nanocapsules containing a lipophilic drug |
| EP2500015A1 (en) * | 2006-12-05 | 2012-09-19 | Landec Corporation | Delivery of drugs |
| JP4621218B2 (ja) | 2007-02-09 | 2011-01-26 | 有限会社バイオ研 | Ｔｈ１誘導剤及びその製造方法 |
| US9814553B1 (en) * | 2007-10-10 | 2017-11-14 | Abbott Cardiovascular Systems Inc. | Bioabsorbable semi-crystalline polymer for controlling release of drug from a coating |
| WO2009100422A2 (en) * | 2008-02-08 | 2009-08-13 | Zimmer, Inc. | Drug delivery system comprising microparticles and gelation system |
| KR20100117603A (ko) * | 2008-02-13 | 2010-11-03 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 안정화 효과를 갖는 약물 전달 시스템 |
| US8673359B2 (en) | 2010-07-08 | 2014-03-18 | Brown University | Nanoparticle compositions and methods for improved oral delivery of active agents |
| WO2012018616A2 (en) | 2010-07-26 | 2012-02-09 | Anaphore, Inc. | Polypeptides that bind trail-r1 and trail-r2 |
| US20130101553A1 (en) | 2011-04-18 | 2013-04-25 | The Regents Of The University Of California | Inducing inactivation of fibrogenic myofibroblasts |
| JP6174023B2 (ja) * | 2011-07-22 | 2017-08-02 | インノコア テクノロジーズ ビー．ブイ． | 生物活性化合物の制御放出のための生物分解性、半結晶性、相分離、熱可塑性マルチブロックコポリマー |
| WO2013112456A1 (en) | 2012-01-24 | 2013-08-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Controlled release formulations for the induction and proliferation of blood cells |
-
2015
- 2015-08-14 CA CA2957966A patent/CA2957966C/en active Active
- 2015-08-14 WO PCT/US2015/045402 patent/WO2016025911A1/en not_active Ceased
- 2015-08-14 JP JP2017528767A patent/JP6910949B2/ja active Active
- 2015-08-14 AU AU2015301399A patent/AU2015301399B2/en active Active
- 2015-08-14 US US15/503,891 patent/US10722468B2/en active Active
- 2015-08-14 EP EP15756295.0A patent/EP3179985A1/en not_active Withdrawn
-
2020
- 2020-06-23 US US16/909,493 patent/US11504329B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017524743A5 (enExample) | ||
| JP5649783B2 (ja) | Ｈｃｖプロドラッグ処方 | |
| El-Maghawry et al. | Eudragit®-S100 coated PLGA nanoparticles for colon targeting of Etoricoxib: optimization and pharmacokinetic assessments in healthy human volunteers | |
| JP5167345B2 (ja) | 薬剤を加速放出する腸溶コーティングを含む固体剤形 | |
| CN101321517B (zh) | 能够口服和活性成分快速释放的固体药物剂型 | |
| KR101799625B1 (ko) | 제약 또는 기능식품 투여 형태에 적합한 코팅 조성물 | |
| Marquette et al. | Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres | |
| SI21394A2 (sl) | Farmacevtske pelete, ki vsebujejo tamsulozin | |
| EP3362052B1 (en) | Processes for preparing formulations for gastrointestinal-targeted therapies | |
| US20240408050A1 (en) | Dihydromyricetin spray-dried dispersion formulations and methods for forming them | |
| JP2006514698A (ja) | ナノ粒子生物活性物質 | |
| KR101902602B1 (ko) | 에탄올의 영향에 대해 내성을 갖는 위 내성 제약 또는 기능식품 조성물 | |
| WO2005084639A2 (en) | Polymeric drug delivery system for hydrophobic drugs | |
| JP2006514698A5 (enExample) | ||
| EP4037659B1 (en) | Pharmaceutical composition comprising enzalutamide | |
| JP2019518758A (ja) | 粘膜付着性材料によって被覆された個々のコア単位を有するコアと腸溶性コアコーティングを備えた多単位投薬形態 | |
| JP2023505714A (ja) | アルカリ剤及び腸溶性コーティング層を含む剤形 | |
| Kumar et al. | Solid dispersion-strategy to enhance solubility and dissolution of poorly water soluble drugs | |
| JP2016519133A (ja) | ポリマーフィルムコーティングされた医薬組成物の薬物放出プロフィールを安定化させるための方法 | |
| JP2017536350A (ja) | ナノ粒子放出腸溶性ミクロ粒子の調製 | |
| TW200829287A (en) | Short term slow release drug delivery system | |
| CN101668515B (zh) | 药物组合物和方法 | |
| CN103347931B (zh) | 制备用于药物剂型的稳定保护性衣层的粉末包衣剂 | |
| JP5841609B2 (ja) | Ｈｃｖ感染症を処置するための医薬組成物 | |
| JP2021523137A (ja) | 生体吸収性ポリエステル、親水性ポリマーおよびアシル化ヒトラクトフェリン由来ペプチドを含むナノ粒子 |